Skip to main content

Table 3 Isolated microbes in infected Vancomycin treated and Vancomycin untreated patients

From: Effectiveness of topical vancomycin in the prevention of spinal surgical site infections: a retrospective cohort study

Isolated microbe*

Total number of isolates

N = 36

Vancomycin treated

N = 11

Vancomycin untreated

N = 25

Methicillin-susceptible Staphylococcus aureus no. (%)

8

1 (9%)

7 (28%)

MRSA no. (%)

4

2 (18%)

2 (8%)

Coagulase-negative Staphylococci no. (%)±

4

2 (18%)

2 (8%)

Klebsiella pneumoniae

4

1 (9%)

3 (12%)

Escherichia coli

4

2 (18%)

2 (8%)

Enterobacter cloacae

1

0 (0%)

1 (4%)

Morganella morganii

2

1 (9%)

1 (4%)

Pseudomonas aeruginosa

6

1 (9%)

5 (20%)

Mycobacterium tuberculosis&

2

0 (0%)

2 (8%)

Acinetobacter baumannii

1

1 (9%)

0 (0%)

  1. *Samples for culture sensitivity were taken from a swab as deep as possible during the follow-up visits upon the presence of signs/symptoms of infection. Tissue samples (e.g. bone or fascia) were taken in the operation room under general anesthesia in case of revision/debridement. Species confirmation was performed using Vitek® System
  2. ±One isolate was methicillin- susceptible Staphylococcus hominis, the other was methicillin- resistant Staphylococcus epidermidis. The species of the other two isolates were not identified, but one was methicillin resistant and the other was methicillin susceptible
  3. &Assessment for Mycobacterium tuberculosis was performed for patients with signs/symptoms and/or history of tuberculosis infection
Back to article page

Antimicrobial Resistance & Infection Control

ISSN: 2047-2994

Contact us